Medtech Insights

The European market for TEO devices will be driven by adoption of innovative and premium-priced products, incremental device improvements, as well as rising penetration of endovascular…

The European spinal implant market will see moderate growth through 2027, driven by relatively high spending on health care and physician training, a growing elderly population, and improving…

The European market for dialysis access treatment devices is a dynamic market that will grow moderately through 2027, driven by the availability of novel and innovative products. However, market…

The European dental biomaterial market will grow moderately through 2027, driven by an increasing number of GDs offering dental implant therapy and widespread awareness of dental implant…

A highly cost-conscious health care landscape in Europe has placed substantial downward pressure on the large yet contracting European IC device market. However, an expanding CAD patient pool…

The European IC device market will continue to grow through 2027, driven largely by expanding procedure volumes—spurred by innovations that allow for the use of PCI in more complex patient…

Through 2027, the Eastern European market for IC devices will expand modestly, with the expanding CAD population supporting an increase in procedure volumes. However, overall revenue growth…

The mature European IC device market will grow slightly through 2027, driven largely by continuing increases in procedure volumes, driven largely by continuing increases in procedure volumes…

The European market for heart valve devices will grow through 2027, fueled by an expanding aging population and rising adoption THV devices, reflecting the accumulation of favorable clinical data…

The European market for heart valve devices will grow through 2027, fueled by an expanding aging population and rising adoption THV devices, reflecting the accumulation of favorable clinical data…

The European drug delivery device market will see modest growth through 2027. Although the increasing availability of biosimilars will negatively impact ASPs, the greater affordability of lower-…

The European market for PV devices is evolving, and new product launches backed by clinical evidence will allow for significant expansion through 2027. This Medtech 360 Report provides…